Jun 11, 2019 - QIAGEN (QGEN) is enjoying investors' high confidence, courtesy of the QIAstat-Dx system.
Jun 06, 2019 - QIAGEN (QGEN) expects multi-site clinical validations for this new system during 2020 Lyme disease season.
May 28, 2019 - QIAGEN's (QGEN) therascreen PIK3CA Kit is the first companion diagnostic test to have attained premarket approval from the FDA.
May 23, 2019 - This acclaim marks a giant leap for QIAGEN (QGEN) in the field of tuberculosis diagnosis.
May 07, 2019 - QGEN earnings call for the period ending March 31, 2019.
May 07, 2019 - Qiagen NV (NYSE:QGEN) Q1 2019 Earnings Conference Call May 07, 2019, 09:00 ET Company Participants John Gilardi - VP, Corporate Communications & IR Peer Schatz - CEO Roland Sackers - CFO Conferenc
May 06, 2019 - Qiagen (QGEN) delivered earnings and revenue surprises of 3.85% and -0.76%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
May 03, 2019 - QIAGEN (QGEN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Apr 29, 2019 - Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Apr 16, 2019 - QIAGEN (QGEN) introduces the FDA approved companion diagnostic test to help in guiding therapy in any cancer identification.